Exploring The SARC044 Trial
Dr. Candace Haddox will present an overview of the Phase II SARC044 Clinical Trial.
Updates from CTOS
Dr. Alcindor will discuss scientific updates relevant to GIST patients that were exhibited at the Connective Tissue Oncology Society (CTOS) conference.
Know Your Mutation: Why is Biomarker Testing Important in GIST?
Michelle Harris and Calvin Chao of Tempus will discuss the importance of biomarker testing in GIST, the process of biomarker testing, how to get testing done for free through The LRG, and more.
GDOL North Carolina Virtual
GDOL North Carolina is being held virtually Nov 6th, 3-5 pm ET at Chapel Hill, North Carolina.
GDOL Miami Virtual
GDOL Miami is being held virtually with the GIST experts at Sylvester Comprehensive Cancer Center.
GDOL Calgary
Join us for a full day GIST Day of Learning event in Calgary, Alberta on Saturday September 28, 2024.
IDRX-42: Trial Design & Emerging Data from StrateGIST 1
Dr. Suzanne George of the Dana-Farber Cancer Institute will review emerging data from the first-in-human StrateGIST 1 trial of IDRX-42 in patients with advanced GIST.
Locoregional Therapies for Treatment of GIST in the Liver
Dr. Kim of Mount Sinai Medical Center will describe various locoregional therapies and their appropriate uses, as well as the role of locoregional therapies and systemic therapy in treating GIST when it metastasizes in the liver.
Managing Side Effects of GIST Therapies
Dr. Weiss of Washington University School of Medicine in St. Louis will provide an overview of GIST treatments and side effects as well as home management for each type of symptom.
GDOL Ohio 2024
GDOL Ohio is being held in-person at The Ohio State University Wexner Medical Center, Biomedical Research Tower (BRT), 460 W 12th Ave, Room 115, Columbus, OH 43210